Australia's Wellnex Life rises on upbeat H2 update
** Wellnex Life WNX.AX rises 6.3% to A$0.17, highest since December 9 ** Consumer healthcare business sees H2 FY26 EBITDA improving by A$2.4 million ($1.6 million) vs prior comparative period ** Adds December EBITDA rose A$0.7 million vs last year, helped by lower operating costs ** WNX tanked 84.3% last year ($1 = A$1.4921) (Reporting by Nikita Maria Jino in Bengaluru) ((Nikita.Jino@thomsonreuters.com;))
Recent news on Wellnex Life
See all newsWellnex Life Limited - Director’s dealing
Wellnex Life Limited - Completion and Settlement of Sale of Pain Away
Wellnex Life Limited - Change of Chief Financial Officer
Wellnex Life Limited - Annual Report for Year Ended 30 June 2026
Wellnex Life Limited - Posting of EGM Notice and Explanatory Memorandum